Joyce(Varughese-Raju)VarugheseMD

PubMed

• 1 citations
  Fluorodeoxyglucose positron-emission tomography-magnetic resonance hybrid imaging: An emerging tool for staging of cancer of the uterine cervix
  Alina Nazir, Robert Matthews, Annapurneswara Rao Chimpiri, Melissa Henretta, Joyce Varughese, Dinko Franceschi> ;World Journal of Nuclear Medicine. 2021 Apr 1
• 1 citations
  Malignant recurrence of Female Adnexal Tumor of Probable Wolffian Origin (FATWO).
  Amal Amir, Katherine Jane Chua, Joyce Varughese> ;Gynecologic Oncology Reports. 2020 Oct 29
• 6 citations
  Social needs in gynecologic oncology: A Society of Gynecologic Oncology (SGO) clinical practice statement.
  Katharine M. Esselen, Abdulrahman K. Sinno, Joyce Varughese, Stephanie L. Wethington, E. Prendergast, Christina Chu> ;Gynecologic Oncology. 2020 Jul 18
• 6 citations
  Accuracy in Referrals to Gynecologic Oncologists Based on Clinical Presentation for Ovarian Mass.
  Katherine Jane Chua, Ricky D. Patel, Radhika Trivedi, Patricia Greenberg, Kyle Beiter, Thomas Magliaro, Ushma Patel, Joyce Varughese> ;Diagnostics. 2020 Feb 16
• 5 citations
  Uterine torsion with necrosis of bilateral adnexa in a postmenopausal woman.
  Katherine Jane Chua, Ricky D. Patel, Armina Eana, Joyce Varughese> ;BMJ Case Reports. 2019 Jun 18
• 21 citations
  Mechanisms of resistance to HER2-targeted therapies in HER2-amplified uterine serous carcinoma, and strategies to overcome it.
  Gulden Menderes, Salvatore Lopez, Chanhee Han, Gary Altwerger, Stepan Gysler, Joyce Varughese, Peter E. Schwartz, Alessandro D. Santin> ;Discovery Medicine. 2018 Aug 1
• 16 citations
  Novel targeted therapies in ovarian and uterine carcinosarcomas.
  Chanhee Han, Gary Altwerger, Gulden Menderes, Kaitlin Haines, Jacqueline Feinberg, Salvatore Lopez, Aranzazu Manzano, Joyce Varughese, Alessandro D. Santin> ;Discovery Medicine. 2018 Jun 1
• 235 citations
  Landscape of somatic single-nucleotide and copy-number mutations in uterine serous carcinoma.
  Siming Zhao, Murim Choi, John D. Overton, Stefania Bellone, Dana M. Roque, Emiliano Cocco, Federica Guzzo, Diana P. English, Joyce Varughese, Sara Gasparrini, Ileana B...> ;Proceedings of the National Academy of Sciences of the United States of America. 2013 Feb 19
• 1 citations
  Syndrome of Inappropriate Antidiuretic Hormone after vinorelbine treatment
  Mai Hoang, Joyce Varughese, Elena Ratner> ;Journal of Oncology Pharmacy Practice. 2013 Jan 24
• 32 citations
  HER2/neu as a potential target for immunotherapy in gynecologic carcinosarcomas
  Federica Guzzo, Stefania Bellone, Natalia Buza, Pei Hui, Luisa Carrara, Joyce Varughese, Emiliano Cocco, Marta Betti, Paola Todeschini, Sara Gasparrini, Peter E. Schwa...> ;International Journal of Gynecological Pathology. 2012 May 1
• 20 citations
  A survey of gynecologic oncologists regarding the end-of-life discussion: a pilot study.
  K. ElSahwi, Jessica L. Illuzzi, Joyce Varughese, Nina Carusillo, Elena Ratner, Dan-Arin Silasi, Masoud Azodi, Peter E. Schwartz, Thomas J. Rutherford, Alessandro D. Sa...> ;Gynecologic Oncology. 2012 Mar 1
• 60 citations
  Eradication of chemotherapy-resistant CD44+ human ovarian cancer stem cells in mice by intraperitoneal administration of clostridium perfringens enterotoxin†
  Francesca Casagrande, Emiliano Cocco, Stefania Bellone, Christine E. Richter, Marta Bellone, Paola Todeschini, Eric R. Siegel, Joyce Varughese, Dan Arin-Silasi, Masoud...> ;Cancer. 2011 Dec 15
• 33 citations
  Cervical carcinomas overexpress human trophoblast cell-surface marker (Trop-2) and are highly sensitive to immunotherapy with hRS7, a humanized monoclonal anti-Trop-2 ...
  Joyce Varughese, Emiliano Cocco, Stefania Bellone, Elena Ratner, Dan-Arin Silasi, Masoud Azodi, Peter E. Schwartz, Thomas J. Rutherford, Natalia Buza, Sergio Pecorelli...> ;American Journal of Obstetrics and Gynecology. 2011 Dec 1
• 25 citations
  Trop-2 overexpression in poorly differentiated endometrial endometrioid carcinoma: implications for immunotherapy with hRS7, a humanized anti-trop-2 monoclonal antibody.
  Eliana Bignotti, Antonella Ravaggi, Chiara Romani, Marcella Falchetti, Silvia Lonardi, Fabio Facchetti, Sergio Pecorelli, Joyce Varughese, Emiliano Cocco, Stefania Bel...> ;International Journal of Gynecological Cancer. 2011 Dec 1
• 18 citations
  Clear cell cancer of the uterine corpus: the association of clinicopathologic parameters and treatment on disease progression.
  Joyce Varughese, Pei Hui, Lingeng Lu, Herbert Yu, Peter E. Schwartz> ;Journal of Oncology. 2011 Nov 30
• 32 citations
  Uterine and ovarian carcinosarcomas overexpressing Trop-2 are sensitive to hRS7, a humanized anti-Trop-2 antibody
  Rhoda Raji, Federica Guzzo, Luisa Carrara, Joyce Varughese, Emiliano Cocco, Stefania Bellone, Marta Betti, Paola Todeschini, Sara Gasparrini, Elena Ratner, Dan-Arin Si...> ;Journal of Experimental & Clinical Cancer Research. 2011 Nov 10
• 27 citations
  Her2/neu extracellular domain shedding in uterine serous carcinoma: implications for immunotherapy with trastuzumab.
  Paola Todeschini, Emiliano Cocco, Stefania Bellone, Joyce Varughese, Ken Yu Lin, Luisa Carrara, Federica Guzzo, Natalia Buza, Pei Hui, Dan-Arin Silasi, Elena Ratner, M...> ;British Journal of Cancer. 2011 Oct 11
• 9 citations
  Expression of αV-integrins in uterine serous papillary carcinomas; implications for targeted therapy with intetumumab (CNTO 95), a fully human antagonist anti-αV-integ...
  Marta Bellone, Emiliano Cocco, Joyce Varughese, Stefania Bellone, Paola Todeschini, K. ElSahwi, Luisa Carrara, Federica Guzzo, Peter E. Schwartz, Thomas J. Rutherford,...> ;International Journal of Gynecological Cancer. 2011 Aug 1
• 43 citations
  Uterine serous papillary carcinomas overexpress human trophoblast-cell-surface marker (trop-2) and are highly sensitive to immunotherapy with hRS7, a humanized anti-tr...
  Joyce Varughese, Emiliano Cocco, Stefania Bellone, Maria C. De Leon, Marta Bellone, Paola Todeschini, Peter E. Schwartz, Thomas J. Rutherford, Sergio Pecorelli, Alessa...> ;Cancer. 2011 Jul 15
• 29 citations
  Tissue factor expression in ovarian cancer: implications for immunotherapy with hI-con1, a factor VII-IgGF c chimeric protein targeting tissue factor
  Emiliano Cocco, Joyce Varughese, Natalia Buza, Stefania Bellone, Ken Yu Lin, Marta Bellone, Paola Todeschini, Dan-Arin Silasi, Masoud Azodi, Peter E. Schwartz, Thomas ...> ;Clinical & Experimental Metastasis. 2011 Jul 2
• 37 citations
  High-grade, chemotherapy-resistant primary ovarian carcinoma cell lines overexpress human trophoblast cell-surface marker (Trop-2) and are highly sensitive to immunoth...
  Joyce Varughese, Emiliano Cocco, Stefania Bellone, Marta Bellone, Paola Todeschini, Luisa Carrara, Peter E. Schwartz, Thomas J. Rutherford, Sergio Pecorelli, Alessandr...> ;Gynecologic Oncology. 2011 Jul 1
• 27 citations
  Expression of tissue factor in adenocarcinoma and squamous cell carcinoma of the uterine cervix: implications for immunotherapy with hI-con1, a factor VII-IgGFc chimer...
  Emiliano Cocco, Joyce Varughese, Natalia Buza, Stefania Bellone, Michelle Glasgow, Marta Bellone, Paola Todeschini, Luisa Carrara, Dan-Arin Silasi, Masoud Azodi, Peter...> ;BMC Cancer. 2011 Jun 22
• 35 citations
  Cancer Care Inequity for Women in Resource-Poor Countries
  Joyce Varughese, Susan Richman> ;Reviews in Obstetrics & Gynecology. 2010 Jan 1
• 124 citations
  Increased Tie2 Expression, Enhanced Response to Angiopoietin-1, and Dysregulated Angiopoietin-2 Expression in Hemangioma-Derived Endothelial Cells
  Ying Yu, Joyce Varughese, Lawrence F. Brown, John B. Mulliken, Joyce Bischoff> ;The American Journal of Pathology. 2001 Dec 1
• Join now to see all